bisindolylmaleimide i has been researched along with Hypertrophy in 2 studies
bisindolylmaleimide I: a bis(indolyl)maleimide
Hypertrophy: General increase in bulk of a part or organ due to CELL ENLARGEMENT and accumulation of FLUIDS AND SECRETIONS, not due to tumor formation, nor to an increase in the number of cells (HYPERPLASIA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, S | 1 |
| Hypolite, JA | 1 |
| Mohanan, S | 1 |
| Zderic, SA | 1 |
| Wein, AJ | 1 |
| Chacko, S | 1 |
| Adams, JW | 1 |
| Sah, VP | 1 |
| Henderson, SA | 1 |
| Brown, JH | 1 |
2 other studies available for bisindolylmaleimide i and Hypertrophy
| Article | Year |
|---|---|
Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder.
Topics: Animals; Disease Models, Animal; Humans; Hypertrophy; In Vitro Techniques; Indoles; Male; Maleimides | 2009 |
Tyrosine kinase and c-Jun NH2-terminal kinase mediate hypertrophic responses to prostaglandin F2alpha in cultured neonatal rat ventricular myocytes.
Topics: Animals; Animals, Newborn; Calcium-Calmodulin-Dependent Protein Kinases; Cells, Cultured; Cyclic AMP | 1998 |